Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Biochim Biophys Acta. 2016 Oct 18;1866(2):320–329. doi: 10.1016/j.bbcan.2016.10.005

Fig. 3.

Fig. 3

Hypothetical model of TMM selection and therapeutic targeting during metastasis. The top row (blue box) depicts the dissemination of a telomerase-positive cancer cell from the primary tumor site to a distant organ, while the bottom row (pink box) depicts these same events in an ALT-positive cell. See Section 5. “Telomere homeostasis: Determinant or consequence of metastatic progression?” for details.